Breast Re-irradiation After Second Ipsilateral Lumpectomy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age40+
SponsorYoussef Zeidan

About this trial

The purpose of this research study is to test the safety and possible harms of treating breast cancer with reirradiation, after breast surgery. The researchers want to find out what effects (good and bad) reirradiation has on people who have already received radiation before surgery.

Eligibility criteria

Qualifiers

Diagnosed with ER+HER2- breast cancer

Provision of signed and dated ICF

Stated willingness to comply with all study procedures and availability for the duration of the study

Age ≥ 40 years

Disqualifiers

BRCA1/2 mutation or any other receptor subtypes

Individuals assigned male at birth with breast cancer

Pregnancy or breastfeeding

Skin involvement

Trial design

Treatments tested in this trial

  • Intensity modulated radiation therapy (IMRT)

Treatment groups

114 Participants
are divided into 1 treatment group

Sponsors and collaborators

Youssef Zeidan

Lead sponsor

Baptist Health South Florida

Sponsor institution

Boca Raton Regional Hospital Foundation

Collaborator